![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/29 | |
A61K 33/10 | |||
A61P 19/08 | |||
A61P 19/10 | |||
A61P 43/00 |
(11) | Number of the document | 2682125 |
(13) | Kind of document | T |
(96) | European patent application number | 13181715.7 |
Date of filing the European patent application | 2010-09-08 | |
(97) | Date of publication of the European application | 2014-01-08 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
2009208039 | 2009-09-09 | JP |
(72) |
Shirae, Shinichiro, JP
Nakamura, Yasuo, JP
Oya, Yuiko, JP
Nozaki, Yoshihide, JP
Kobayashi, Nobuyuki, JP
Kuroda, Tatsuhiko, JP
Kato, Hiroki, JP
Serada, Masashi, JP
Hori, Kazuyoshi, JP
|
(73) |
Asahi Kasei Pharma Corporation,
1-1-2 Yurakucho, Chiyoda-ku Tokyo 100-0006,
JP
|
(54) | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |
PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |